Daewoong Pharmaceutical Reaches Sales of KRW 1.16 Trillion in 2022, Fexuclue Leads The Highest Revenue

/PRNewswire/ -- Daewoong Pharmaceutical (CEO Seng-ho Jeon, Chang-jae Lee) announced its 2022 annual report. On a standalone basis, sales increased from the...

Related Keywords

Germany ,Seoul ,Soult Ukpyolsi ,South Korea ,Australia ,Thailand ,Brazil ,China ,Ecuador ,Austria ,Russia , ,Daewoong Pharmaceutical Co Ltd ,Ministry Of Food ,Chang Jae Lee ,Daewoong Pharmaceutical ,Global Innovative ,Fast Track ,Drug Safety ,Daewoong Pharmaceutical Co ,Td ,